Nature's Sunshine Products is a fifty-year herbal manufacturer that just handed the franchise to a packaged-goods operator and asked the market to underwrite a doubling plan off a mature consultant network. The June quarter is the first clean look at that wager. Constant-currency sales still advanced, factory margins widened to 73.7%, and the North America digital channel kept compounding. The shares have given back most of last year's re-rating because China reversed from a prior growth run into a sharp contraction and the company cut the year.
The factory is not the problem facing equity holders this year. Gross profit absorbed the China hole and still expanded, which is the opposite of a broken cost structure. The problem is whether Vision for Growth, the new campaign to push digital tools, new-country launches, and acquisitions toward a billion-dollar sales ambition, can outrun a consultant model that still depends on Asia and still pays about 30.6% of sales in volume incentives. Adjusted earnings before interest, taxes, depreciation and amortization sat flat at $11.3 million, so the margin lift was spent as fast as it was earned.
Cash of $82.5 million and an undrawn revolving line give the new team time. The next two quarters decide whether Japan and digital North America keep carrying the P&L, or whether China and a stronger dollar keep forcing the outlook lower. Does a mid-single-digit organic company deserve a growth multiple, or is the current discount the honest price of a turn that has not yet earned one?